Community post

Fernando Gordillo Altamirano (Monash University) and colleagues published a new paper on phage therapy failure mechanisms, showing pre-existing anti-prophage antibodies and bacterial heteroresistance contributed to treatment failure in a patient with chronic Bordetella bronchialis infection.